跳至主要内容
临床试验/NL-OMON25809
NL-OMON25809暂停不适用

A multicentre, open-label, randomized comparison of once daily insulin detemir given pre-breakfast or bedtime, according to need, with bedtime insulin glargine in people with type 2 diabetes characterized by an asymmetric insulin requirement between the day and night.

Dr. J.H. de VriesAcademic Medical Center - AmsterdamandProf. Philip HomeUniversity of Newcastle upon Tyne, UK0 个研究点目标入组 175 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
暂停
发起方
入组人数
175

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. People with type 2 diabetes who have received treatment with either twice daily NPH insulin or a twice daily regimen of a human or analogue (30/70) premix insulin, either regimen for at least 2 months, with or without concomitant use of OGLDs, and;
  • 2. A ratio of evening insulin dose:morning insulin dose >1.3:1 (nocturnal hepatic glucose output subgroup), or

排除标准

  • 1. Patients with HbA1c >9.0 or <6.5 % at entry visit;
  • 2. Patients with body mass index >40.0 kg/m2 at entry visit;

研究者

发起方
Dr. J.H. de VriesAcademic Medical Center - AmsterdamandProf. Philip HomeUniversity of Newcastle upon Tyne, UK

相似试验

进行中(未招募)
1 期
A multicentre, open-label, randomized comparison of once daily insulin detemir given pre-breakfast or bedtime, according to need, with bedtime insulin glargine in people with type 2 diabetes characterized by an asymmetric insulin requirement between the day and night. - BirdsongMedDRA version: 8.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusDiabetes Mellitus
EUCTR2006-002047-92-GBewcastle Primary Care Trust146
已完成
3 期
A clinical study to evaluate the efficacy, safety and tolerability of Picotamide chewable tablets 300mg vs. Aspirin tablets 325mg in patients requiring antiplatelet therapy.
CTRI/2010/091/000588Ajanta Pharma Ltd200
已完成
不适用
A randomized, multicentre, open label trial comparing the start of the induction of labor with intravenous oxytocin according to the circadian rhythm with standard care.Induction of labor with intravenous oxytocin.
NL-OMON22012AMC:J.J.H. Bakker, Dr.J.A.M. van der Post, Dr.R. de Vos.OLVG: Dr.J.M.M.van LithSLVZ:Drs.A.J.van Veelen400
已完成
3 期
A clinical trial to study the effects of two drugs, fixed dose combination capsules of Celecoxib and Diacerein and fixed dose combination tablets of Aceclofenac and Diacerein in patients with osteoarthritis of knee and/or hip joints.
CTRI/2010/091/000053Cadila Healthcare Ltd200
已完成
3 期
A clinical trial to study effectiveness and safety of Fixed dose combination tablets of Hyoscine butylbromide & Mefenamic acid in patients suffering from paroxysmal spastic abdominal pai
CTRI/2011/091/000141Cadila Healthcare Ltd200